SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367920-19-000019
Filing Date
2019-03-01
Accepted
2019-03-01 16:43:47
Documents
4
Period of Report
2019-03-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2019atm-form8xk.htm 8-K 32174
2 EXHIBIT 1.1 openmarketsaleagreement-fi.htm EX-1.1 249260
3 EXHIBIT 5.1 a51opinion-2019atm.htm EX-5.1 11210
4 GOODWIN LOGO a51opinion2019atmimage1.jpg GRAPHIC 25886
  Complete submission text file 0001367920-19-000019.txt   329679
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36310 | Film No.: 19650122
SIC: 2834 Pharmaceutical Preparations